NO166284C

Purified hematoporphyrin derivative for diagnosis and treatment of tumors, and method.

Abstract

A method of synthesizing and purifying a high molecular weight aggregate, derived from hematoporphyrin, said material being useful in the localization and treatment of tumors. The substance results from the hydrolysis of the reaction mixture of hematoporphyrin and acetic-sulfuric acids. The material is purified by cycling the crude product through a micro-porous membrane system in which exclusion of low molecular weight by-products is effected. The substance is tumor-selective and photosensitizing. It is retained in tumors longer than in normal tissues and fluoresces red to aid in diagnosis. Strong illumination of tumors retaining the substance results in necrosis, while normal tissues which have generally eliminated the drug remain unaffected. The high molecular weight aggregate has an empirical formula of approximately C68H70N8O11 (Na plus H)4.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

54 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
42464782United States of AmericaA
48134583United States of AmericaA
8301379United States of AmericaW

Members54

Family members, oldest first
DocumentOfficeKind
WO8401382A1World Intellectual Property Organization (WIPO)A1
AU2032283AAustraliaA
DK261384ADenmarkA
DK261384D0DenmarkD0
NO842089LNorwayL
EP0120054A1European Patent Office (EPO)A1
JPS60500132AJapanA
EP0120054A4European Patent Office (EPO)A4
DK210185D0DenmarkD0
DK210185ADenmarkA
NO851897LNorwayL
NO941548LNorwayL
AU4246185AAustraliaA
EP0161606A2European Patent Office (EPO)A2
JPS6113AJapanA
DE161606T1GermanyT1
CN85103992AChinaA
US4649151AUnited States of AmericaA
AU581840B2AustraliaB2
US4866168AUnited States of AmericaA
AU588806B2AustraliaB2
US4889129AUnited States of AmericaA
EP0161606A3European Patent Office (EPO)A3
CA1265450ACanadaA
EP0120054B1European Patent Office (EPO)B1
US4932934AUnited States of AmericaA
AT53204TAustriaT
ATE53204T1AustriaT1
DE3381616D1GermanyD1
CA1271746ACanadaA
CA1275452CCanadaC
CN1011571BChinaB
NO166284BNorwayB
US5015463AUnited States of AmericaA
NO166284CThis recordNorwayC
US5028621AUnited States of AmericaA
MX9203266AMexicoA
US5145863AUnited States of AmericaA
EP0161606B1European Patent Office (EPO)B1
DE3587296D1GermanyD1
US5225433AUnited States of AmericaA
DE3587296T2GermanyT2
JPH06105921AJapanA
NO941548D0NorwayD0
NO176786BNorwayB
NO176786CNorwayC
JPH084631B2JapanB2
JP2532368B2JapanB2
NL940021I1Netherlands (Kingdom of the)I1
NO180742BNorwayB
NL940021I2Netherlands (Kingdom of the)I2
NO180742CNorwayC
DK172284B1DenmarkB1
DK175615B1DenmarkB1